Furthermore, treatment with thiazolidinediones (PPAR-γ agonist) in patients with plaque psoriasis improved their cutaneous symptoms (Pershadsingh et al., 1998; Ellis et al., 2000). This evidence concerns the gene PPARG and psoriasis vulgaris.